Description: PharmaMore provides a forum for industry leaders to hear the most important voices and ideas in the industry. PharmaMore is a leading industry publication operated by Pharma More. Our stories spark ideas and shape agendas for 5+ million decision makers in the most competitive industries.
After a big 2023, Yoshi Shitaka said the company is banking on gene therapies, KRAS degraders and more to keep the momentum. Read more ➔
Patent thickets are the latest target in lawmakers' bid to lower drug prices.
Explosive demand for weight loss drugs has propelled both companies to new heights. Here’s a look at the staggering growth, by the numbers.